CLASS III BETA-TUBULIN EXPRESSION IN NON-SMALL CELL LUNG CANCER AS A PREDICTIVE MARKER FOR PACLITAXEL

被引：0

作者：

Ohashi, Takuya ^{[1
]}

Yoshimasu, Tatsuya ^{[1
]}

Oura, Shoji ^{[1
]}

Kokawa, Yozo ^{[1
]}

Nakamura, Rie ^{[1
]}

Kawago, Mitsumasa ^{[1
]}

Hirai, Yoshimitsu ^{[1
]}

Nishiguchi, Haruka ^{[1
]}

Matsutani, Masako ^{[1
]}

Honda, Mariko ^{[1
]}

Okamura, Yoshitaka ^{[1
]}

机构：

[1] Wakayama Med Univ, Dept Thorac & Cardiovasc Surg, Wakayama, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

Class III beta-tubulin; histoculture drug response assay; Lung cancer; predictive marker;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.01-021

引用

页码：S437 / S437

页数：1

共 50 条

[1] Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response
Ohashi, Takuya
Yoshimasu, Tatsuya
Oura, Shoji
Kokawa, Yozo
Kawago, Mitsumasa
Hirai, Yoshimitsu
Miyasaka, Miwako
Aoishi, Yuka
Kiyoi, Megumi
Nishiguchi, Haruka
Honda, Mariko
Okamura, Yoshitaka
ANTICANCER RESEARCH, 2015, 35 (05) : 2669 - 2674
[2] Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer
Koh, Youngil
Jang, Bogun
Han, Sae-Won
Kim, Tae-Min
Oh, Do-Youn
Lee, Se-Hoon
Kang, Chang Hyun
Kim, Dong-Wan
Im, Seock-Ah
Chung, Doo Hyun
Kim, Young Tae
Kim, Tae-You
Kim, Young-Whan
Kim, Joo Hyun
Heo, Dae Seog
Bang, Yung-Jue
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 320 - 325
[3] Is Class III β-Tubulin a True Predictive Marker of Sensitivity to Vinorelbine in Non-small Cell Lung Cancer? Chemosensitivity Data Evidence
Hirai, Yoshimitsu
Yoshimasu, Tatsuya
Oura, Shoji
Ota, Fuminori
Naito, Koma
Nishiguchi, Haruka
Hashimoto, Sayoko
Okamura, Yoshitaka
ANTICANCER RESEARCH, 2011, 31 (03) : 999 - 1005
[4] Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
Azuma, Koichi
Sasada, Tetsuro
Kawahara, Akihiko
Takamori, Sinzo
Hattori, Satoshi
Ikeda, Jiro
Itoh, Kyogo
Yamada, Akira
Kage, Masayoshi
Kuwano, Michihiko
Aizawa, Hisamichi
LUNG CANCER, 2009, 64 (03) : 326 - 333
[5] Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations
Monzó, M
Rosell, R
Sánchez, JJ
Lee, JS
O'Brate, A
González-Larriba, JL
Alberola, V
Lorenzo, JC
Núñez, L
Ro, JY
Martin, C
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1786 - 1793
[6] Expression of class III beta tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy
Dumontet, C
Seve, P
Isaac, S
Tredan, O
Souquet, P
Pacheco, Y
Perol, M
Lafanéchère, L
Penet, A
Peiller, E
LUNG CANCER, 2005, 49 : S243 - S243
[7] Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel
Sève, P
Mackey, J
Isaac, S
Trédan, O
Souquet, PJ
Pérol, M
Lai, R
Voloch, A
Dumontet, C
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (12) : 2001 - 2007
[8] Expression of estrogen receptors and beta-III tubulin in non-small cell lung cancer tissue
Ponomarenko, E. A.
Mamichev, I. A.
Bogush, T. A.
Ryabinina, O. M.
Dyakova, J. B.
Novikov, D. V.
Polotsky, B. E.
Davydov, M. M.
ANNALS OF ONCOLOGY, 2017, 28
[9] Evaluation of class III beta-tubulin (bTubIII) expression as a prognostic marker in patients with resectable non-small cell lung cancer (NSCLC) treated by perioperative chemotherapy (CT) in the phase III trial IFCT-0002
Zalcman, G.
Levallet, G.
Bergot, E.
Antoine, M.
Creveuil, C.
Brambilla, E.
Dumontet, C.
Morin, F.
Depierre, A.
Milleron, B.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[10] The association of Snail expression with ERCC1 and beta-tubulin class III expression in cisplatin and paclitaxel resistance of lung cancer cells
Hung, Jung-Jyh
Wu, Kou-Juey
CANCER RESEARCH, 2012, 72

← 1 2 3 4 5 →